恩帕吉菲
医学
痛风
尿酸
内科学
肾脏疾病
肾功能
安慰剂
糖尿病
危险系数
内分泌学
高尿酸血症
肌酐
泌尿科
胃肠病学
2型糖尿病
置信区间
病理
替代医学
作者
Kaitlin J. Mayne,Rebecca J. Sardell,Natalie Staplin,Parminder K. Judge,Doreen Zhu,Emily Sammons,David Z.I. Cherney,Jennifer B. Green,Adeera Levin,Roberto Pontremoli,Sibylle J. Hauske,Jonathan Emberson,David Preiss,Martin Landray,Colin Baigent,Christoph Wanner,Richard Haynes,William G. Herrington,the EMPA-KIDNEY Collaborative Group,Colin Baigent
摘要
SGLT2 inhibition reduces serum uric acid in patients with CKD, with larger effects at higher eGFR and in the absence of diabetes. However, the effect on uric acid is modest and did not translate into reduced risk of gout in EMPA-KIDNEY.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
OK
GingerF
cdercder
Copyright
Nole
奋斗易真
斯文钢笔
arniu2008
天穹雨
无极微光
1111111111
初景
Haiverxin
不潮薯饼
Zephyrite
sswbzh
QZR
学术文献互助
sagitar
皖公网安备34019202002308
